We are live on ! Find out more
KBG

Kahn Brothers Group Portfolio holdings

AUM $564M
1-Year Est. Return 25.3%
This Fund
S&P 500
This Quarter Est. Return
+11.51%
1 Year Est. Return
+25.3%
3 Year Est. Return
+38.07%
5 Year Est. Return
+72.96%
10 Year Est. Return
+308.37%
AUM
$581M
AUM Growth
-$106M
Cap. Flow
-$91.9M
Cap. Flow %
-15.82%
Top 10 Hldgs %
73.88%
Holding
44
New
–
Increased
3
Reduced
30
Closed
2

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$62.1M
2
BP icon
BP
BP
+$1.43M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$18.7M
2
NYT icon
New York Times
NYT
+$16M
3
ORI icon
Old Republic International
ORI
+$15.8M
4
C icon
Citigroup
C
+$15.2M
5
FLG
Flagstar Bank National Association
FLG
+$14.2M

Sector Composition

Rank Sector Weight
1 Financials 33.67%
2 Healthcare 21.05%
3 Communication Services 12.2%
4 Energy 11.02%
5 Technology 5.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NYT icon
1
New York Times
NYT
$12.4B
$67.6M 11.64%
4,261,658
-1,178,200
-22% -$16M
PFE icon
2
Pfizer
PFE
$143B
$58.2M 10.01%
2,002,346
-641,088
-24% -$18.7M
C icon
3
Citigroup
C
$221B
$56M 9.63%
1,074,173
-300,800
-22% -$15.2M
FLG
4
Flagstar Bank National Association
FLG
$6.4B
$55.1M 9.48%
1,089,889
-292,540
-21% -$14.2M
ORI icon
5
Old Republic International
ORI
$10.1B
$42.5M 7.32%
2,461,710
-963,218
-28% -$15.8M
PTEN icon
6
Patterson-UTI
PTEN
$3.66B
$35.7M 6.14%
1,408,280
-562,200
-29% -$13.5M
MRK icon
7
Merck
MRK
$315B
$30.3M 5.21%
2,646,594
+1,359,091
+106% +$62.1M
HOLX
8
DELISTED
Hologic
HOLX
$30.2M 5.19%
1,349,570
-200,200
-13% -$4.41M
VOXX
9
DELISTED
VOXX International Corporation Class A
VOXX
$28M 4.83%
1,679,342
-657,750
-28% -$10.4M
MBI icon
10
MBIA
MBI
$328M
$25.5M 4.39%
2,135,230
-849,550
-28% -$9.79M
BP icon
11
BP
BP
$106B
$25.3M 4.36%
636,635
+38,498
+6% +$1.43M
SEB icon
12
Seaboard Corp
SEB
$4.4B
$25.1M 4.32%
8,986
-4,400
-33% -$12.2M
NTP
13
DELISTED
Nam Tai Property Inc.
NTP
$19.6M 3.38%
2,747,667
-1,000,000
-27% -$7.56M
STL
14
DELISTED
Sterling Bancorp
STL
$15.1M 2.61%
1,132,740
-6,300
-0.6% -$76.6K
NVS icon
15
Novartis
NVS
$291B
$2.2M 0.38%
30,543
-2,232
-7% -$155K
STRP
16
DELISTED
Straight Path Communications Inc.
STRP
$2M 0.34%
244,047
-91,666
-27% -$601K
XOM icon
17
ExxonMobil
XOM
$605B
$1.81M 0.31%
17,934
– –
FNFG
18
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
$1.59M 0.27%
149,382
-1,000
-0.7% -$10.8K
BB icon
19
BlackBerry
BB
$5.37B
$1.49M 0.26%
200,000
-190,000
-49% -$1.34M
BMY icon
20
Bristol-Myers Squibb
BMY
$124B
$1.47M 0.25%
27,650
-650
-2% -$33.1K
CMCSA icon
21
Comcast
CMCSA
$86.1B
$1.27M 0.22%
48,688
-1,160
-2% -$27.9K
BAC icon
22
Bank of America
BAC
$432B
$888K 0.15%
57,021
– –
CVX icon
23
Chevron
CVX
$366B
$885K 0.15%
7,088
– –
ASTE icon
24
Astec Industries
ASTE
$1.29B
$773K 0.13%
20,000
-106,000
-84% -$3.76M
IBM icon
25
IBM
IBM
$206B
$616K 0.11%
3,434
– –
1
2

Similar funds

AHSW
Adventist Health System West Roseville, California $564M AUM 17.1% 1-Year Est. Return
LC
Lavaca Capital Houston, Texas $564M AUM 4.6% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return
TCP
ThornTree Capital Partners Boston, Massachusetts $564M AUM 36.37% 1-Year Est. Return
OC
Opal Capital Boca Raton, Florida $565M AUM
KF
KKM Financial Chicago, Illinois $563M AUM 28.2% 1-Year Est. Return
AAS
Asset Allocation Strategies Farmington, Michigan $563M AUM 15.65% 1-Year Est. Return
PEP
Providence Equity Partners Providence, Rhode Island $565M AUM 37.52% 1-Year Est. Return

Kahn Brothers Group's Q4 2013 Portfolio in Review

As of Q4 2013, Kahn Brothers Group held 44 positions worth $581M, down 15% from $687M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Kahn Brothers Group withdrew a net $91.9M in Q4 2013, closing 2 positions and reducing 30 holdings. Its most notable exit was FIRST PL FINL CORP DEL, an estimated $21 position sold in full.

By sector, the portfolio is most concentrated in Financials at 34% of assets, up from 33% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Kahn Brothers Group added an estimated $62.1M to Merck.

  • Kahn Brothers Group added most to Merck in Q4 2013, an estimated $62.1M increase.
  • Kahn Brothers Group's biggest Q4 2013 reduction was Pfizer, cutting an estimated $18.7M.
  • Kahn Brothers Group fully exited FIRST PL FINL CORP DEL in Q4 2013, selling an estimated $21.
  • Kahn Brothers Group's ten largest holdings make up 74% of its $581M portfolio in Q4 2013.
  • Kahn Brothers Group opened 0 new positions and closed 2 in Q4 2013.
  • Kahn Brothers Group's portfolio value fell 15% quarter-over-quarter to $581M.

Based on Kahn Brothers Group's 13F filing for Q4 2013, filed 4 Feb 2014.